Revenue | ₹75.92Cr |
Net Profits | ₹10.95Cr |
Net Profit Margins | 14.42% |
Jagsonpal Pharmaceuticals Ltd’s revenue fell -23.72% since last year same period to ₹75.92Cr in the Q3 2025-2026. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated -2.03% fall in its revenue since last 3-months.
Jagsonpal Pharmaceuticals Ltd’s net profit fell -65.77% since last year same period to ₹10.95Cr in the Q3 2025-2026. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated -12.89% fall in its net profits since last 3-months.
Jagsonpal Pharmaceuticals Ltd’s net profit margin fell -55.13% since last year same period to 14.42% in the Q3 2025-2026. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated -11.09% fall in its net profit margins since last 3-months.
The revenue for Jagsonpal Pharmaceuticals Ltd in the Q3 results 2025 was ₹75.92Cr.
The net profit for Jagsonpal Pharmaceuticals Ltd in the Q3 results 2025 was ₹10.95Cr.
The net profit margin for Jagsonpal Pharmaceuticals Ltd in the Q3 results 2025 was 14.42%.
The revenue for Jagsonpal Pharmaceuticals Ltd in the Q3 results 2024 was ₹99.53Cr.
The net profit for Jagsonpal Pharmaceuticals Ltd in the Q3 results 2024 was ₹31.99Cr.
The net profit margin for Jagsonpal Pharmaceuticals Ltd in the Q3 results 2024 was 32.14%.